share_log

Reported Earlier, Myriad Genetics Engages Unitedhealthcare On Pharmacogenetic Testing Policy, Seeks Continued Access To Genesight In 2025

Reported Earlier, Myriad Genetics Engages Unitedhealthcare On Pharmacogenetic Testing Policy, Seeks Continued Access To Genesight In 2025

早前报道,万基遗传与联合健康公司就药物基因组测试政策进行合作,寻求在2025年继续使用Genesight。
Benzinga ·  12/11 15:35

Reported Earlier, Myriad Genetics Engages Unitedhealthcare On Pharmacogenetic Testing Policy, Seeks Continued Access To Genesight In 2025

早前报道,万基遗传与联合健康公司就药物基因组测试政策进行合作,寻求在2025年继续使用Genesight。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发